Jifang G. Sheng

415 Feng Yang Road
Changzheng, 200003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Journal: American journal of hematology
Published: March 20, 2026

Mycobacterium arosiense Infection in a Patient with CD209 Mutation: A Rare Case Report.

Mycobacterium arosiense Infection in a Patient with CD209 Mutation: A Rare Case Report.

Journal: Infection and drug resistance
Published: October 07, 2025

Phagocyte-inspired supramolecular self-assembly design of abiotic cell-mimics for pathogen recognition and eradication.

Phagocyte-inspired supramolecular self-assembly design of abiotic cell-mimics for pathogen recognition and eradication.

Journal: Acta biomaterialia
Published: October 04, 2025

Advancements in Understanding the Role of Oxylipins in Liver Injury and Liver Failure.

Advancements in Understanding the Role of Oxylipins in Liver Injury and Liver Failure.

Journal: Journal of clinical and translational hepatology
Published: September 26, 2025

Applications of Artificial Intelligence and Smart Devices in Metabolic Dysfunction-associated Steatotic Liver Disease.

Applications of Artificial Intelligence and Smart Devices in Metabolic Dysfunction-associated Steatotic Liver Disease.

Journal: Journal of clinical and translational hepatology
Published: August 09, 2025

Single-cell analysis identifies RETN+ monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.

Single-cell analysis identifies RETN+ monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.

Journal: Gut
Published: May 29, 2025

Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.

Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.

Journal: Journal of clinical and translational hepatology
Published: May 07, 2025

Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study.

Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study.

Journal: European journal of medical research
Published: May 06, 2025

Dissecting the liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure.

Dissecting the liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure.

Journal: Hepatology (Baltimore, Md.)
Published: February 24, 2025

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis.

Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis.

Journal: BMC gastroenterology
Published: August 25, 2024

Factors associated with glucocorticoid dosing in treating patients with noncritical COVID-19 pneumonia: Insights from an artificial intelligence-based CT imaging analysis.

Factors associated with glucocorticoid dosing in treating patients with noncritical COVID-19 pneumonia: Insights from an artificial intelligence-based CT imaging analysis.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: August 09, 2024

Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure.

Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure.

Journal: eGastroenterology
Published: May 31, 2024
Showing 1-12 of 139

Last Updated: 09/26/2026